Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hai Liang

Showing results (1-10 of 1,367) with videos related to

Pageof 137
Sort By:
Plos One|August 20, 2015
Testing Propositions Derived from Twitter Studies: Generalization and Replication in Computational Social ScienceHai Liang, King-Wa Fu
Current Topics in Medicinal Chemistry|November 26, 2020
Privileged Scaffolds for Drug Design and Activity Improvement-Part IYongtao Duan, Hai-Liang Zhu
Current Topics in Medicinal Chemistry|December 16, 2021
Privileged Scaffold for Drug Design and Activity Improvement - Part IIIYongtao Duan, Hai-Liang Zhu
Anti-Cancer Agents in Medicinal Chemistry|April 29, 2011
Resveratrol and its analogues: promising antitumor agentsXianfeng Huang, Hai-Liang Zhu
World Journal of Microbiology & Biotechnology|April 8, 2017
Comparative metagenomics reveals insights into the deep-sea adaptation mechanism of the microorganisms in Iheya hydrothermal fieldsHai-Liang Wang, Li Sun
Current Topics in Medicinal Chemistry|June 16, 2022
Privileged Scaffold for Drug Design and Activity Improvement - Part VYongtao Duan, Hai-Liang Zhu
Anti-Cancer Agents in Medicinal Chemistry|April 8, 2021
Nitrogenous Heterocyclic Moiety for Drug DiscoveryYongtao Duan, Hai-Liang Zhu
International Journal of Molecular Sciences|June 26, 2026
The Versatile Applications of Antisense Oligonucleotides in Modern MedicineXue-Hai Liang, Lingdi Zhang
Anti-Cancer Agents in Medicinal Chemistry|April 28, 2011
Nitroimidazoles as anti-tumor agentsKai Liu, Hai-Liang Zhu
Current Topics in Medicinal Chemistry|March 16, 2022
Privileged Scaffold for Drug Design and Activity Improvement - Part IVYongtao Duan, Hai-Liang Zhu
Pageof 137

Showing results (1-10 of 1,367) with videos related to

Sort By:
Pageof 137
Plos One|August 20, 2015
Testing Propositions Derived from Twitter Studies: Generalization and Replication in Computational Social ScienceHai Liang, King-Wa Fu
Current Topics in Medicinal Chemistry|November 26, 2020
Privileged Scaffolds for Drug Design and Activity Improvement-Part IYongtao Duan, Hai-Liang Zhu
Current Topics in Medicinal Chemistry|December 16, 2021
Privileged Scaffold for Drug Design and Activity Improvement - Part IIIYongtao Duan, Hai-Liang Zhu
Anti-Cancer Agents in Medicinal Chemistry|April 29, 2011
Resveratrol and its analogues: promising antitumor agentsXianfeng Huang, Hai-Liang Zhu
World Journal of Microbiology & Biotechnology|April 8, 2017
Comparative metagenomics reveals insights into the deep-sea adaptation mechanism of the microorganisms in Iheya hydrothermal fieldsHai-Liang Wang, Li Sun
Current Topics in Medicinal Chemistry|June 16, 2022
Privileged Scaffold for Drug Design and Activity Improvement - Part VYongtao Duan, Hai-Liang Zhu
Anti-Cancer Agents in Medicinal Chemistry|April 8, 2021
Nitrogenous Heterocyclic Moiety for Drug DiscoveryYongtao Duan, Hai-Liang Zhu
International Journal of Molecular Sciences|June 26, 2026
The Versatile Applications of Antisense Oligonucleotides in Modern MedicineXue-Hai Liang, Lingdi Zhang
Anti-Cancer Agents in Medicinal Chemistry|April 28, 2011
Nitroimidazoles as anti-tumor agentsKai Liu, Hai-Liang Zhu
Current Topics in Medicinal Chemistry|March 16, 2022
Privileged Scaffold for Drug Design and Activity Improvement - Part IVYongtao Duan, Hai-Liang Zhu
Pageof 137